CLINICAL_TRIALS ClinicalTrials.gov record update

Quality of Life and Preference of COPD Patients After Switching From Tiotropium Monotherapy (Spiriva® Handihaler®) to Dual Therapy With Tiotropium Bromide Plus Olodaterol (Spiolto® Respimat®) Under Real Life Conditions in Greece (ELLACTO II Study)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04672941
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:25.975652+00:00
Published At: 2023-11-28T00:00:00+00:00
Record Updated At: 2024-06-25
Results Posted At: 2023-11-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pulmonary Disease, Chronic Obstructive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-06-25"
protocolSection.identificationModule.nctId: "NCT04672941"
protocolSection.identificationModule.officialTitle: "Quality of Life and Preference of COPD Patients After Switching From Tiotropium Monotherapy (Spiriva\u00ae Handihaler\u00ae) to Dual Therapy With Tiotropium Bromide Plus Olodaterol (Spiolto\u00ae Respimat\u00ae) Under Real Life Conditions in Greece (ELLACTO II Study)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-11-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.